Study compares risk with 2 diabetes drugs
( American Heart Association ) A new analysis of data on patients covered by a single insurance company reports that risks of heart disease events and death were no different between patients who took the diabetes drugs rosiglitazone or pioglitazone. In this analysis, approximately 4 percent of patients taking either drug — sold as Avandia and Actos — suffered a heart attack, heart failure …
Read more on EurekAlert!
Study compares risk with 2 diabetes drugs
In contrast to previous reports, the risks of the composite endpoint of heart attack, heart failure, both, or death were the same – about 4 percent – for patients taking the diabetes drugs rosiglitazone or pioglitazone, according to a study published in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.
Study Compares Risk With Two Diabetes Drugs
Study highlights:
Read more on PR Newswire via Yahoo! News
Related posts:
- Study: No esophageal cancer risk from bone drugs
- Fast Pulse (Elevated Heart Rate) Over Long Term Linked To High Risk Of Death
- FDA cautions about heart risk with Parkinson’s drug Stalevo
- Cholesterol drugs raise diabetes risk by 9 percent – Natural News.com
- Disease risk for men taking drugs for sex function
Tags: compares, diabetes, Drugs, risk, study